BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Outpost Medicine Taps Pfizer Alum as New CMO

  Dr. Mills will be responsible for the company’s global clinical development and regulatory operations.

  December 5, 2017

   · 

  2 min read
• Business

  AccuTec Blades Announces Exclusive Australia-New Zealand DermaBlade Agreement

  AccuTec Blades has entered into an agreement with Diplomat Blades to distribute DermaBlade throughout Australia and New Zealand.

  December 5, 2017

   · 

  1 min read
• Pharm Country

  Illinois Hospital, Affiliated Imaging Centers Install Nine Carestream DR Systems to Deliver Rapid Image Access, Excellent Image Quality

  The hospital and its affiliated outpatient and urgent care clinics began converting to digital radiography several years ago to achieve improved image quality, higher staff productivity and rapid image access for physicians.

  December 5, 2017

   · 

  4 min read
• Business

  Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration

  Check-Cap will supply GE with supporting calibration and final assembly methodology and equipment.

  December 5, 2017

   · 

  3 min read
• 

  Drug Development

  Galectin Tanks as NASH Drug Flunks Phase IIb Trial

  There was a positive trend in the total group of patients but the difference did not reach statistical significance for this primary endpoint.

  December 5, 2017

   · 

  10 min read
• CV Sciences Repays Installment Obligation on Convertible Debt

  Company avoids dilution to stockholders.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P With Checkpoint Inhibitor

  Preliminary data suggest immuno-oncology applications for drug candidate.

  December 5, 2017

   · 

  4 min read
• Drug Development

  100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression

  In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with increasing prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

  December 5, 2017

   · 

  4 min read
• Biotech Bay

  Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy

  Bio-Rad today announces the launch of the QXDx BCR-ABL %IS Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with CML to therapy, and it does so more precisely and reliably than other available technologies.

  December 5, 2017

   · 

  4 min read
• Biotech Bay

  New Aurora Advanced Flow Cytometry System from Cytek Biosciences Resonates with Researchers Around the World

  In just a few short months, the Aurora advanced flow cytometry system from Cytek Biosciences Inc. has made a distinct impression on the scientific community.

  December 5, 2017

   · 

  2 min read